| 10-Q | 2020-10-31 | Filed 2020-12-15 |
| 10-Q | 2020-07-31 | Filed 2020-09-21 |
| 10-K | 2020-04-30 | Filed 2020-08-11 |
| 10-Q | 2020-01-31 | Filed 2020-03-16 |
| 10-Q | 2019-10-31 | Filed 2019-12-16 |
| 10-Q | 2019-07-31 | Filed 2019-09-13 |
| 10-K | 2019-04-30 | Filed 2019-08-05 |
| 10-Q | 2019-01-31 | Filed 2019-03-18 |
| 10-Q | 2018-10-31 | Filed 2018-12-17 |
| 10-Q | 2018-07-31 | Filed 2018-09-10 |
| 10-K | 2018-04-30 | Filed 2018-07-30 |
| 10-Q | 2018-01-31 | Filed 2018-03-19 |
| 10-Q | 2017-10-31 | Filed 2017-12-14 |
| 10-Q | 2017-07-31 | Filed 2017-09-20 |
| 10-K | 2017-04-30 | Filed 2017-09-08 |
| 10-Q | 2017-01-31 | Filed 2017-05-26 |
| 10-Q | 2016-10-31 | Filed 2017-02-17 |
| 10-Q | 2016-07-31 | Filed 2017-02-17 |
| 10-K | 2016-04-30 | Filed 2017-02-17 |
| 10-Q | 2016-01-31 | Filed 2017-02-14 |
| 10-Q | 2015-10-31 | Filed 2017-02-14 |
| 10-Q | 2015-07-31 | Filed 2017-02-14 |
| 10-Q | 2015-04-30 | Filed 2017-02-14 |
| 10-Q | 2015-01-31 | Filed 2015-07-24 |
| 10-Q | 2014-10-31 | Filed 2014-12-22 |
| 10-Q | 2014-07-31 | Filed 2014-09-24 |
| 10-K | 2014-04-30 | Filed 2014-08-18 |
| 10-Q | 2014-01-31 | Filed 2014-03-17 |
| 10-Q | 2013-10-31 | Filed 2013-12-23 |
| 8-K | 2020-11-05 | |
| 8-K | 2020-09-30 | |
| 8-K | 2020-08-23 | |
| 8-K | 2020-08-12 | |
| 8-K | 2020-03-24 | |
| 8-K | 2019-12-18 | |
| 8-K | 2019-09-24 | |
| 8-K | 2019-08-06 | |
| 8-K | 2019-03-25 | |
| 8-K | 2018-05-21 | |
| 8-K | 2018-05-14 |
| Comps ($'000 TTM) | Market Cap | Gross Margin | EV/EBITDA | Ret on Assets | Assets | Liabilities | Revenue | G Profit | Net Income | EBITDA | EV |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 024 Pharma (EEIG) | |||||||||||
| 11 Good Energy (ELVN) | |||||||||||
| 1347 Capital Corp (TFSC) | |||||||||||
| Ameren Illinois Co (AILNP) | |||||||||||
| 1PM Industries (OPMZ) | |||||||||||
| 1st Century Bancshares (FCTY) | |||||||||||
| 1st Financial Services Corp (FFIS) | |||||||||||
| 1st United Bancorp (FUBC) | |||||||||||
| 2-Track Global (TTG) | |||||||||||
| ENTERGY ARKANSAS, LLC (EAI) | |||||||||||
| 21st Century Oncology Holdings (RTSX) | |||||||||||
| 24Holdings (TWFH) | |||||||||||
| Bioquest Corp (BQST) | |||||||||||
| 30DC (TDCH) | |||||||||||
| BriaCell Therapeutics Corp. (BCTXW) | |||||||||||
| DD3 Acquisition Corp. II (DDMXW) | |||||||||||
| 3D Total Solutions (DTLS) | |||||||||||
| 3DX Industries (DDDX) | |||||||||||
| 8i Acquisition 2 Corp. (LAX) | |||||||||||
| ALABAMA POWER CO (APRCP) |
| Balance Sheet ($'000) | 2013-07-31 | 2013-10-31 | 2014-01-31 | 2014-04-30 | 2014-07-31 | 2014-10-31 | 2015-01-31 | 2015-04-30 | 2016-04-30 | 2016-07-31 | 2016-10-31 | 2017-01-31 | 2017-04-30 | 2017-07-31 | 2017-10-31 | 2018-01-31 | 2018-04-30 | 2018-07-31 | 2018-10-31 | 2019-01-31 | 2019-04-30 | 2019-07-31 | 2019-10-31 |
| Cash | 1 | 1 | 4 | 2 | 0 | 3 | 5 | 5 | 1 | 0 | 1 | 0 | 3 | 0 | 3 | 21 | 2 | 17 | 5 | 46 | 19 | 0 | 31 |
| Accounts Receivable | 2 | 15 | 7 | 7 | 7 | 42 | 6 | 39 | 0 | ||||||||||||||
| Inventory | |||||||||||||||||||||||
| PP&E | 1,111 | 1,016 | 921 | 540 | 445 | 349 | 254 | 0 | |||||||||||||||
| Assets | 1 | 1 | 4 | 2 | 581 | 1,847 | 1,982 | 1,313 | 702 | 565 | 433 | 305 | 20 | 10 | 38 | 137 | 98 | 105 | 84 | 151 | 719 | 767 | 2,193 |
| Accounts Payable | 79 | 77 | 76 | 75 | 73 | 180 | 186 | 290 | 289 | 288 | 287 | 285 | 284 | 282 | 286 | 279 | 279 | 279 | 279 | 279 | 279 | 279 | |
| Long-Term Debt | 314 | 314 | 314 | 314 | 314 | 314 | |||||||||||||||||
| Liabilities | 692 | 697 | 711 | 712 | 1,134 | 2,268 | 2,724 | 2,261 | 2,486 | 2,512 | 2,541 | 2,572 | 2,610 | 2,652 | 1,812 | 1,809 | 1,582 | 1,588 | 1,571 | 1,622 | 1,585 | 1,588 | 1,554 |
| Stockholders' Equity | -691 | -696 | -707 | -711 | -553 | -421 | -742 | -948 | -1,784 | -1,947 | -2,108 | -2,268 | -2,591 | -2,642 | -1,774 | -1,672 | -1,484 | -1,484 | -1,487 | -1,471 | -865 | -821 | 639 |
| Income Statement ($'000) | 2013-07-31 | 2013-10-31 | 2014-01-31 | 2014-04-30 | 2014-07-31 | 2014-10-31 | 2015-01-31 | 2015-04-30 | 2016-04-30 | 2016-07-31 | 2016-10-31 | 2017-01-31 | 2017-04-30 | 2017-07-31 | 2017-10-31 | 2018-01-31 | 2018-04-30 | 2018-07-31 | 2018-10-31 | 2019-01-31 | 2019-04-30 | 2019-07-31 | 2019-10-31 |
| Revenue | 2 | 1 | 2 | -1 | 17 | 54 | 183 | -146 | 4 | 6 | 1 | 11 | 2 | 24 | 44 | 41 | 92 | 69 | 121 | 732 | 119 | 717 | |
| Cost of Revenue | 1 | 0 | 0 | 0 | 0 | 10 | 27 | 29 | 0 | 0 | 0 | 0 | 15 | 9 | 5 | 8 | 14 | -1 | 2 | 2 | |||
| Gross Profit | 1 | 1 | 2 | -1 | 16 | 44 | 156 | -175 | 4 | 6 | 1 | 11 | 29 | 32 | 87 | 61 | 108 | 733 | 116 | 715 | |||
| R&D | |||||||||||||||||||||||
| SG&A | 5 | 1 | 9 | -2 | 186 | 283 | 226 | 137 | 42 | 43 | 46 | 61 | 70 | 44 | 25 | 43 | 76 | 57 | 9 | 15 | 3 | 30 | |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 0 | 0 | ||
| Net Income | -8 | -5 | -12 | -3 | 154 | 298 | -321 | -451 | -163 | -161 | -166 | -338 | -109 | 212 | -32 | 59 | -7 | -20 | 12 | 598 | 24 | 542 | |
| Cash Flow ($'000) | 2013-07-31 | 2013-10-31 | 2014-01-31 | 2014-04-30 | 2014-07-31 | 2014-10-31 | 2015-01-31 | 2015-04-30 | 2016-04-30 | 2016-07-31 | 2016-10-31 | 2017-01-31 | 2017-04-30 | 2017-07-31 | 2017-10-31 | 2018-01-31 | 2018-04-30 | 2018-07-31 | 2018-10-31 | 2019-01-31 | 2019-04-30 | 2019-07-31 | 2019-10-31 |
| Cash Operating | -8 | -4 | -9 | 0 | -7 | -3 | -46 | -25 | -0 | 1 | -4 | -11 | -38 | -5 | 12 | -18 | 17 | -8 | -19 | -18 | 34 | ||
| Cash Investing | |||||||||||||||||||||||
| Cash Financing | 6 | 4 | 11 | -2 | 6 | 5 | 48 | 25 | -1 | 3 | 14 | 35 | 8 | 6 | -1 | -2 | -3 | -7 | -1 | -3 | |||